Saybrook Capital’s Bristol-Myers Squibb BMY Stock Holding History

Saybrook Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,863	Closed	-$368K	–	41
2024 Q2	$368K	Sell	8,863 -6,000	-40%	-$268K	0.1%	38
2024 Q1	$806K	Hold	14,863	–	–	0.21%	34
2023 Q4	$763K	Hold	14,863	–	–	0.21%	32
2023 Q3	$863K	Hold	14,863	–	–	0.26%	29
2023 Q2	$950K	Hold	14,863	–	–	0.28%	28
2023 Q1	$1.03M	Sell	14,863 -87	-0.6%	-$6.14K	0.33%	28
2022 Q4	$1.08M	Buy	14,950 +87	+0.6%	+$6.56K	0.36%	28
2022 Q3	$1.06M	Hold	14,863	–	–	0.37%	27
2022 Q2	$1.14M	Hold	14,863	–	–	0.37%	28
2022 Q1	$1.08M	Sell	14,863 -83	-0.6%	-$5.57K	0.29%	28
2021 Q4	$932K	Sell	14,946 -8	-0.1%	-$469	0.23%	32
2021 Q3	$885K	Sell	14,954 -43	-0.3%	-$2.83K	0.24%	31
2021 Q2	$1M	Buy	14,997 +134	+0.9%	+$8.74K	0.27%	30
2021 Q1	$938K	Hold	14,863	–	–	0.28%	30
2020 Q4	$922K	Hold	14,863	–	–	0.3%	29
2020 Q3	$896K	Hold	14,863	–	–	0.32%	27
2020 Q2	$874K	Hold	14,863	–	–	0.35%	28
2020 Q1	$828K	Hold	14,863	–	–	0.38%	29
2019 Q4	$954K	Hold	14,863	–	–	0.37%	30
2019 Q3	$754K	Hold	14,863	–	–	0.32%	30
2019 Q2	$674K	Hold	14,863	–	–	0.28%	32
2019 Q1	$709K	Hold	14,863	–	–	0.31%	33
2018 Q4	$773K	Hold	14,863	–	–	0.37%	33
2018 Q3	$923K	Sell	14,863 -375	-2%	-$22.3K	0.4%	33
2018 Q2	$843K	Hold	15,238	–	–	0.39%	33
2018 Q1	$964K	Hold	15,238	–	–	0.46%	32
2017 Q4	$934K	Hold	15,238	–	–	0.43%	35
2017 Q3	$971K	Hold	15,238	–	–	0.48%	33
2017 Q2	$849K	Hold	15,238	–	–	0.43%	35
2017 Q1	$829K	Buy	15,238 +6,063	+66%	+$333K	0.45%	36
2016 Q4	$536K	Hold	9,175	–	–	0.34%	35
2016 Q3	$495K	Buy	9,175 +375	+4%	+$24.1K	0.32%	34
2016 Q2	$647K	Hold	8,800	–	–	0.42%	34
2016 Q1	$562K	Hold	8,800	–	–	0.36%	35
2015 Q4	$605K	Hold	8,800	–	–	0.38%	37
2015 Q3	$521K	Hold	8,800	–	–	0.35%	39
2015 Q2	$586K	Hold	8,800	–	–	0.37%	35
2015 Q1	$568K	Hold	8,800	–	–	0.37%	34
2014 Q4	$519K	Hold	8,800	–	–	0.3%	39
2014 Q3	$450K	Hold	8,800	–	–	0.27%	38
2014 Q2	$427K	Hold	8,800	–	–	0.26%	40
2014 Q1	$457K	Hold	8,800	–	–	0.29%	39
2013 Q4	$468K	Hold	8,800	–	–	0.3%	41
2013 Q3	$407K	Hold	8,800	–	–	0.3%	40
2013 Q2	$393K	Buy	+8,800	New	+$382K	0.28%	40

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Saybrook Capital's BMY Position: Q3 2024 in Review

Saybrook Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 8,863 shares — an estimated $368K sold.

Saybrook Capital first reported a position in BMY in Q2 2013 and held it in 45 quarters. The position peaked at $1.14M in Q2 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Saybrook Capital reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Saybrook Capital sold 8,863 Bristol-Myers Squibb shares in Q3 2024, an estimated $368K.
Saybrook Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 45 quarters.
Saybrook Capital's Bristol-Myers Squibb position peaked at $1.14M in Q2 2022.
2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Saybrook Capital's 13F filing for Q3 2024, filed 25 Oct 2024.